Attorney General Aaron M. Frey announced a settlement agreement with Sanofi-Aventis U.S. LLC after scrutiny over the company’s pricing of insulin products.

In the latest move to cement its “immunology powerhouse” status, Sanofi is handing ove | The CD20-directed antibody, dubbed ...

Sanofi is set to acquire DR-0201 from Dren Bio for up to $1.9 billion, aiming to expand its autoimmune disease pipeline with ...

The deal is the latest in a series of Sanofi investments in its immunology portfolio. According to Sanfoi, DR-0201 can ...

Sanofi on Thursday announced an agreement with biopharmaceutical company Dren Bio for the acquisition of its autoimmune ...

Under the settlement, Mainers who are uninsured or have commercial health insurance will be eligible to purchase monthly supplies of Sanofi insulin products through 2029 for $35 cash. This includes ...

The US Food and Drug Administration (FDA) is evaluating under priority review the regulatory submission by French pharma ...

Sanofi (SNY) and Dren Bio, a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi has ...

Banks such as Goldman Sachs (GS) and Citigroup (C) have launched an EUR 7.45B, or $8.1B, debt sale to finance Clayton Dubilier & Rice’s ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.